Bell, Alan http://orcid.org/0000-0002-1012-7334
Kendler, David L. http://orcid.org/0000-0001-7679-3965
Khan, Aliya A. http://orcid.org/0000-0003-3733-8956
Shapiro C.M., Marla
Morisset, Anne
Leung, Jean-Pierre
Reiner, Maureen http://orcid.org/0000-0002-3768-5053
Colgan, Stephen M.
Slatkovska, Lubomira http://orcid.org/0000-0001-5027-7989
Packalen, Millicent
Funding for this research was provided by:
Amgen Canada
Article History
Received: 1 December 2021
Accepted: 18 April 2022
First Online: 6 May 2022
Declarations
:
: AB has received research grants, speaker honoraria, and/or consultancies from Amgen, AstraZeneca, Bausch Health, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, HLS Therapeutics, Janssen, Novartis, Pfizer, Sanofi, and Spectrum Therapeutics. DLK has received research grants, speaker honoraria, and/or consultancies from Alexion, Amgen, BioSyent, and Radius Health. AAK has received research grants from Alexion, Amgen, Ascendis, Chugai, Radius Health, Takeda, and Ultragenyx. MS has received research grants, speaker honoraria, and/or consultancies from Amgen, Aspen, Astellas, Bayer, BioSyent, Duchesnay, GlaxoSmithKline, Merck, Mithra, Pfizer, Searchlight, Sprout, Sunovion, and Therapeutics MD. AM has received speaker honoraria and/or consultancies from Amgen, Eli Lilly, and Sanofi. MR, SMC, LS, and MP are/were employees at the time of study completion and own stock in Amgen. JPL declares no conflict of interest.